StockData
Rallybio Corp logo

Rallybio Corp (RLYB) stock

RLYBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 10/30
$15.29−0.14 (-0.88%)

Close on Nov 17, 2026Market cap $82.32MP/E 3.4Yield –

Rallybio EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

Rallybio's EPS for the twelve months ending Sep 30, 2026 was $4.56. For fiscal 2025 it was -$1.59. The highest annual figure on record is -$1.59 in fiscal 2025.

Annual eps

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$1.59–
FY2024Dec 31, 2024-$10.61–
FY2023Dec 31, 2023-$14.72–
FY2022Dec 31, 2022-$16.72–
FY2021Dec 31, 2021-$14.72–
FY2020Dec 31, 2020-$12.16–

Quarterly eps

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$0.48-116.9%
Q2 FY2026Jun 30, 2026$7.53–
Q1 FY2026Mar 31, 2026-$1.46–
Q4 FY2025Dec 31, 2025-$1.03–
Q3 FY2025Sep 30, 2025$2.84–
Q2 FY2025Jun 30, 2025-$1.76–
Q1 FY2025Mar 31, 2025-$1.69–
Q4 FY2024Dec 31, 2024-$1.98–
Q3 FY2024Sep 30, 2024-$2.08–
Q2 FY2024Jun 30, 2024-$2.96–
Q1 FY2024Mar 31, 2024-$3.76–
Q4 FY2023Dec 31, 2023-$3.98–
Q3 FY2023Sep 30, 2023-$3.60–
Q2 FY2023Jun 30, 2023-$3.68–
Q1 FY2023Mar 31, 2023-$3.44–
Q4 FY2022Dec 31, 2022-$3.64–
Q3 FY2022Sep 30, 2022-$4.80–
Q2 FY2022Jun 30, 2022-$4.56–
Q1 FY2022Mar 31, 2022-$3.84–
Q4 FY2021Dec 31, 2021-$3.31–
Q3 FY2021Sep 30, 2021-$2.96–
Q2 FY2021Jun 30, 2021-$3.92–
Q1 FY2021Mar 31, 2021-$4.80–
Q4 FY2020Dec 31, 2020-$3.78–
Q3 FY2020Sep 30, 2020-$2.56–
Q2 FY2020Jun 30, 2020-$2.37–

More Rallybio figures

See a number that looks wrong?